These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23938070)

  • 21. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC; Barbosa IC; Giordano MG; Haidar MA; Marinho RM; Menegocci JC; Morais KM; Tomaz G; Wehba S
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of cyclooxygenases 1 and 2 in the uterus and breast of cynomolgus monkeys-effects of hormone treatment.
    Zhang H; von Schoultz B; Cline JM; Sahlin L
    Menopause; 2011 Sep; 18(9):1001-9. PubMed ID: 21540754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE; Lambrinoudaki IV; Panoulis CP; Papadias CA; Kouskouni EE; Creatsas GC
    Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys.
    Clarkson TB; Anthony MS; Wagner JD
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5396-404. PubMed ID: 11701713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lipids and apolipoproteins in Greek postmenopausal women: association with estrogen, estrogen-progestin, tibolone and raloxifene therapy.
    Creatsas G; Christodoulakos G; Lambrinoudaki I; Panoulis C; Chondros C; Patramanis P
    J Endocrinol Invest; 2003 Jun; 26(6):545-51. PubMed ID: 12952369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model.
    Ethun KF; Wood CE; Cline JM; Register TC; Appt SE; Clarkson TB
    Menopause; 2013 Jul; 20(7):777-84. PubMed ID: 23793168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
    Kiran H; Kiran G
    Arch Gynecol Obstet; 2006 Apr; 274(1):9-12. PubMed ID: 16369811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
    Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques.
    Isaksson E; Wang H; Sahlin L; von Schoultz B; Cline JM; von Schoultz E
    Breast Cancer Res Treat; 2003 May; 79(2):233-9. PubMed ID: 12825858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Skouby SO; Sidelmann JJ; Nilas L; Jespersen J
    Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys.
    Conner P; Register TC; Skoog L; Tani E; von Schoultz B; Cline JM
    Am J Obstet Gynecol; 2005 Jul; 193(1):58-63. PubMed ID: 16021059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women.
    Valdivia I; Campodónico I; Tapia A; Capetillo M; Espinoza A; Lavín P
    Fertil Steril; 2004 Mar; 81(3):617-23. PubMed ID: 15037411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soy isoflavonoid effects on endogenous estrogen metabolism in postmenopausal female monkeys.
    Wood CE; Register TC; Cline JM
    Carcinogenesis; 2007 Apr; 28(4):801-8. PubMed ID: 17032659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro estrogenic and progestagenic actions of Tibolone.
    Sadarangani A; Salgado AM; Kato S; Pinto M; Carvajal A; Monso C; Owen GI; Vigil P
    Biol Res; 2005; 38(2-3):245-58. PubMed ID: 16238103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential effects on serum IGF-1 of tibolone (5 mg/day) vs combined continuous estrogen/progestagen in post menopausal women].
    Porcile A; Gallardo E; Duarte P; Aedo S
    Rev Med Chil; 2003 Oct; 131(10):1151-6. PubMed ID: 14692305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Skouby SO; Sidelmann JJ; Nilas L; Gram J; Jespersen J
    Climacteric; 2008; 11(6):489-97. PubMed ID: 18991076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.